Cargando…
Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells
Hexokinase II (HKII), a key enzyme of glycolysis, is widely over-expressed in cancer cells. 3-bromopyruvate (3-BrPA), an inhibitor of HK II, has been proposed as a specific antitumor agent. Autophagy is a process that regulates the balance between protein synthesis and protein degradation. Autophagy...
Autores principales: | Zhang, Qianwen, Zhang, Yuanyuan, Zhang, Pei, Chao, Zhenhua, Xia, Fei, Jiang, Chenchen, Zhang, Xudong, Jiang, Zhiwen, Liu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091531/ https://www.ncbi.nlm.nih.gov/pubmed/25053988 |
Ejemplares similares
-
3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants
por: Konstantakou, Eumorphia G., et al.
Publicado: (2015) -
Hexokinase 2 is a molecular bridge linking telomerase and autophagy
por: Roh, Jae-il, et al.
Publicado: (2018) -
Hexokinases in cancer and other pathologies
por: Guo, Dong, et al.
Publicado: (2023) -
Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production
por: Wu, Rongxue, et al.
Publicado: (2012) -
Hexokinase is a key regulator of energy metabolism and ROS activity in insect lifespan extension
por: Lin, Xian-Wu, et al.
Publicado: (2016)